Autor/es reacciones

Ruth Ann Luna

Director, Medical Metagenomics at the Texas Children's Microbiome Center

Associate Professor at Baylor College of Medicine (US)

This type of comprehensive study with adequate and varied control cohorts is much needed to further study the gut-brain axis in autism spectrum disorder (ASD) in depth. The inclusion of other neurodiverse populations, as well as three separate ASD cohorts, clearly contributes to the robustness of this overall study.

The inclusion of diet, gastrointestinal symptom profiles and medication history is crucial, and the only missing piece is a comprehensive behavioural profile, which is especially important as we begin to assess how many of these findings apply specifically to individuals with severe or profound ASD.

EN